PDL-1
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients (NCT07176312) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2026-01-16 |
| Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC (NCT04665609) | Chinese PLA General Hospital | 2021-03-05 |
Track PDL-1 automatically
Every clearance here is in the API, with alerts when new ones post.